Genentech Inc.

• 

  Top 30 401(k) Plans of 2012

  By Ron Pechtimaldjian, AdvisorOne  |  December 12, 2012

  Brightscope, which provides retirement plan ratings and investment research, released its fourth annual Top 30 401(k) plans with more than $1 billion in assets.

• Healthy Pipeline

  By Staff Writer  |  September 1, 2007

  New drug developments, partnerships and clinical-trial results could propel the sector this year, analysts say. --- Larry NeiborRobert W. Baird & Co. 414-765-3791lneibor@rwbaird.com Area of coverage: Specialty Pharmaceuticals Sector...

• Fund in Focus: Constellation Sands Capital Select Growth

  By Staff Writer  |  August 18, 2004

  Frank Sands Jr., manager since July 2000 S&P Rank: 3 Stars Bulking Up On Biotech

• Evan McCulloch of Franklin Biotechnology Discovery Fund

  By Staff Writer  |  March 24, 2004

  S&P Rank: 3 Stars March 11, 2004 Biotechs High on Drug Approvals

• Liu-Er Chen of Evergreen Health Care Fund

  By Staff Writer  |  August 25, 2003

  S&P Rank: 4 Stars Aug. 14, 2003 On the Cusp of a New Drug Boom Quick Take: Drug and biotech stocks suffered in 2002, hurt by poor earnings,...

• Domestic Equity Funds -- July 2003 Review

  By Staff Writer  |  August 11, 2003

  'Rising Tide Lifts All Boats'